Correction to: Molecular targeted drugs resistance impairs double­strand break repair and sensitizes ER­positive breast cancer to PARP inhibitors.

Correction to: Molecular targeted drugs resistance impairs doublestrand break repair and sensitizes ERpositive breast cancer to PARP inhibitors.

Suzuki, Yuna; Wenwen, Wu; Ohta, Tomohiko; Hayashi, Shin-Ichi.

Afiliação

Suzuki Y; Department of Molecular and Functional Dynamics, Graduate School of Medicine, Tohoku University, 2-1 Seoryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
Wenwen W; Department of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Ohta T; Department of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Hayashi SI; Department of Molecular and Functional Dynamics, Graduate School of Medicine, Tohoku University, 2-1 Seoryo-machi, Aoba-ku, Sendai, 980-8575, Japan. shin@med.tohoku.ac.jp.

Breast Cancer ; 29(1): 185, 2022 Jan.

Article em En | MEDLINE | ID: mdl-34420190

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article